VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-27.96%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$60.2M
AUM Growth
+$60.2M
(-31%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monte Rosa Therapeutics
GLUE
$296M
| $26.2M | 43.56% | 5,652,922 | – | – |
|
2
CRISPR Therapeutics
CRSP
$4.71B
| $17M | 28.18% | 498,558 | – | – |
|
|
CTNM
3
Contineum Therapeutics
CTNM
$293M
| $6.41M | 10.64% | 918,163 | – | – |
|
4
Skye Bioscience
SKYE
$108M
| $3.19M | 5.3% | 2,007,704 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $2.61M | 4.33% | 2,646,657 | – | – |
|
6
Tempest Therapeutics
TPST
$44M
| $2.59M | 4.3% | 3,507,055 | – | – |
|
7
Adverum Biotechnologies
ADVM
$64.6M
| $2.21M | 3.68% | 506,821 | – | – |
|